Chronic Lymphocytic Leukemia

Filter By:
08:16
Speaking to the European Medical Journal from the 19th Congress of the European Haematology Association (EHA) meeting, Prof. John Seymour from Sir Peter MacCallum, Department of Oncology, Australia, outlines the three presentations at the meeting updating clinicians on the latest findings with ABT199 , an investigational B-cell lymphoma 2 (BCL-2) s...
by:PatientPowerEU | 100 views
08:13
Speaking to the European Medical Journal from the 19th Congress of the European Haematology Association (EHA) meeting, Prof. John Seymour from Sir Peter MacCallum, Department of Oncology, Australia, outlines the three presentations at the meeting updating clinicians on the latest findings with ABT199 , an investigational B-cell lymphoma 2 (BCL-2) s...
by:EMJ | 120 views
06:24
How are active and progressive CLL disease determined, and how is it used for treatment? Listen to Dr. William Wierda, a world-renowned CLL expert from MD Anderson Cancer Center in Houston, as he provides an explanation. He also outlines the symptoms that patients should monitor and share with their...
by:patientpower | 148 views
04:02
Dr. William Wierda, a CLL expert from MD Anderson Cancer Center in Houston, discusses the importance of clinical trials in order to advance medicine and find a cure. Get email alerts | http://www.p... Subscribe on YouTube | http://www.y... Lik...
by:patientpower | 135 views
09:10
A CLL expert from Leeds University in the UK, Dr. Peter Hillmen shares research highlights from the 2014 European Hematology Association (EHA) meeting in Milan. Dr. Hillmen discusses advances in oral CLL therapies, including ibrutinib (Imbruvica) and developing oral therapies idelalisib and ABT-199. Get email alerts | http://www.p......
by:patientpower | 118 views
02:47
Dr. William Wierda, a world-renowned CLL expert from MD Anderson Cancer Center in Houston, describes the stages of CLL and how the stage of disease can be changed by treatment. Get email alerts | http://www.p... Subscribe on YouTube | http://www.y... Like on Facebook | http://www.f......
by:patientpower | 111 views
06:43
Prognostic factors are characteristics that help to establish a chronic lymphocytic leukemia (CLL) patient's outcome and include test results and a person's medical history. A leading CLL expert from MD Anderson Cancer Center, Dr. William Wierda, explains the role of prognostic factors in understanding how an individual's disease may progress. T...
by:patientpower | 113 views
03:59
What is chronic lymphocytic leukemia (CLL)? As part of Patient Power's Ask the Expert series, Dr. William Wierda, a world-renowned CLL expert from MD Anderson Cancer Center in Houston, offers a definition of the disease and its typical behavior in a patient's body. Get email alerts | http://www.p... Subscribe on YouTu...
by:patientpower | 126 views
07:57
Professors Simon Rule, Peter Hillmen and John Gribben are leading UK clinical researchers with a special interest in CLL. In this brief news report from this year's EHA meeting in Milan they share insights into the promising future for CLL treatment as greater understanding of the biology of this co...
by:PatientPowerEU | 204 views
36:34
In this video from the CLLSA UK Patient Meeting in Cambridge, 21st June, 2014, Patient Advocate Andrew Schorr chairs a panel of UK patient advocates in a discussion of the important roles that advocacy can play in living with and raising awareness of less understood diseases such as CLL. From small ...
by:PatientPowerEU | 95 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)